Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Human Immunoglobulin 16.5% Administered at Modified Dosing Regimens in Patients with Primary Immunodeficiency Diseases - Study Design

被引：0
|
作者：
Melamed, Isaac [1 ]
Gupta, Sudhir [2 ]
Kobayashi, Roger [3 ]
Eppolito, Michael [4 ]
Maltese, Joanna [4 ]
Rizvi, Syed [4 ]
Kobayashi, Ai [5 ]
机构：
[1] IMMUNOe Hlth Ctr, Thornton, CO USA
[2] Univ Calif Irvine, Irvine, CA 92717 USA
[3] Allergy Asthma & Immunol Assoc, Scottsdale, AZ USA
[4] Octapharma, Manchester, Lancs, England
[5] Midlands Pediat, Lexington, SC USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
237
引用
收藏
页码：AB75 / AB75
页数：1
相关论文
共 50 条
  • [1] Subcutaneous Immunoglobulin 16.5% (Cutaquig) in Primary Immunodeficiency Disease: Safety, Efficacy, and Patient Satisfaction with Modified Dosing Regimens
    Gupta, Sudhir
    DeAngelo, James
    Melamed, Isaac
    Walter, Jolan
    Kobayashi, Ai-Lan
    Bridges, Tracy
    Sublett, J. Wesley
    Bernstein, Jonathan
    Koterba, Alan
    Kobayashi, Roger
    CLINICAL IMMUNOLOGY, 2023, 250 : 20 - 21
  • [2] Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
    Sudhir Gupta
    James DeAngelo
    Isaac Melamed
    Jolan E. Walter
    Ai-Lan Kobayashi
    Tracy Bridges
    J. Wesley Sublett
    Jonathan A. Bernstein
    Alan Koterba
    Michael Manning
    Joanna Maltese
    Sonja Hoeller
    Eva Turpel-Kantor
    Huub Kreuwel
    Roger H. Kobayashi
    Journal of Clinical Immunology, 2023, 43 : 1414 - 1425
  • [3] Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
    Gupta, Sudhir
    DeAngelo, James
    Melamed, Isaac
    Walter, Jolan E. E.
    Kobayashi, Ai-Lan
    Bridges, Tracy
    Sublett, J. Wesley
    Bernstein, Jonathan A. A.
    Koterba, Alan
    Manning, Michael
    Maltese, Joanna
    Hoeller, Sonja
    Turpel-Kantor, Eva
    Kreuwel, Huub
    Kobayashi, Roger H. H.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1414 - 1425
  • [4] Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases
    Hans D. Ochs
    Sudhir Gupta
    Peter Kiessling
    Uwe Nicolay
    Melvin Berger
    Journal of Clinical Immunology, 2006, 26 : 265 - 273
  • [5] Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
    Ochs, Hans D.
    Gupta, Sudhir
    Kiessling, Peter
    Nicolay, Uwe
    Berger, Melvin
    JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (03) : 265 - 273
  • [6] Long-Term Safety, Efficacy, and Tolerability of Subcutaneous Human Immunoglobulin 16.5% in Patients with Primary Immunodeficiencies
    Gupta, Sudhir
    Kobayashi, Roger
    Melamed, Isaac
    Rehman, Syed
    Kobayashi, Ai
    Mandujano, jose-Fernando
    Geng, Bob
    Ritchie, Bruce
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB76 - AB76
  • [7] Pharmacokinetics, Efficacy, Tolerability and Safety of a New Subcutaneous Human Immunoglobulin 16.5% in Primary Immune Deficiency
    Kobayashi, Roger
    Gupta, Sudhir
    Melamed, Isaac R.
    Mandujano, Jose F.
    Kobayashi, Ai Lan
    Ritchie, Bruce
    Turpel-Kantor, Eva
    Litzman, Jiri
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (03) : 391 - 392
  • [8] Medium-to-Long-Term Safety, Efficacy, and Tolerability of Subcutaneous Human Immunoglobulin 16.5% in Patients with Primary Immunodeficiencies
    Rizvi, Syed
    Gupta, Sudhir
    Kobayashi, Roger
    Kobayashi, Ai Lan
    Melamed, Isaac
    Mandujano, Jose Fernando
    Geng, Bob
    Rehman, Syed
    Ritchie, Bruce
    Young, Shardae
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S101 - S101
  • [9] Efficacy and Safety of Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases
    Stelmach, I.
    Bal, K.
    Sobocinska, A.
    Zaczeniuk, M.
    Podsiadlowicz-Borzecka, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S304 - S304
  • [10] SAFETY/TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG 20%) IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)
    Paris, Kenneth
    Derfalvi, Beata
    Hussain, Iftikhar
    Haddad, Elie
    Darter, Amy
    Doralt, Jennifer
    Engl, Werner
    McCoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 201 - 202
12345